NEW YORK (GenomeWeb) – Nanosphere today announced a 20-for-1 reverse stock split. 

The reverse split will take effect at 5:00 PM EDT on Wednesday and commence at the open of trading on April 9. Nanosphere's common stock will continue trading on the Nasdaq Capital Market under ticker symbol "NSPH," while a new CUSIP number, 63009F204, has been assigned to the common stock in connection to the reverse split. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.